notoginsenoside R1
(LLPWNQMSUYAGQI-OOSPGMBYSA-N)
Structure
- SMILES
- OC[C@H]1O[C@@H](O[C@H]2C[C@]3(C)[C@@H]([C@@]4([C@@H]2C(C)(C)[C@@H](O)CC4)C)C[C@H]([C@H]2[C@@]3(C)CC[C@@H]2[C@@](O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)(CCC=C(C)C)C)O)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1OC[C@H]([C@@H]([C@H]1O)O)O
- Molecular Formula:
- C47H80O18
- Molecular Weight:
- 933.127
- Log P:
- -0.4169
- Hydrogen Bond Acceptor:
- 18
- Hydrogen Bond Donor:
- 12
- TPSA:
- 298.14
- CAS Number(s):
- 80418-24-2
Synonym(s)
1.
notoginsenoside R1
2.
notoginsenoside R 1
3.
sanchinoside R1
External Link(s)
| MeSH | C072936 |
| PubChem Compound | 441934 |
| ChEBI | 77149 |
| CHEMBL | CHEMBL507115 |
| KEGG | cpd:C08961 |
| ZINC | 238809173 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Acute kidney injury | 20023602 | CTD | |
| 2 | Albuminuria | 25503068 | CTD | |
| 3 | Cardiomyopathies | 23170834 | CTD | |
| 4 | Cardiovascular Diseases | 25152758 | CTD | |
| 5 | Endotoxemia | 9102164 | CTD | |
| 6 | Infarction, Middle Cerebral Artery | 24720662 | CTD | |
| 7 | Inflammation | 25472953 | CTD | |
| 8 | Liver diseases | 18176958 | CTD | |
| 9 | Memory Disorders | 25213453 | CTD | |
| 10 | Myocardial Infarction | 24781185 25305180 | CTD | |
| 11 | Myocardial Reperfusion Injury | 25305180 | CTD | |
| 12 | Osteoporosis | 26362186 | CTD | |
| 13 | Plaque, Atherosclerotic | 24933211 | CTD | |
| 14 | Reperfusion Injury | CTD | ||
| 15 | Ventricular Dysfunction, Left | 23170834 25305180 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.